Nucleus Capital
Aaron Suri is an experienced investor currently working at Nucleus Capital, where responsibilities include supporting early-stage, purpose-driven entrepreneurs in synthetic biology and climate technology since September 2021. Prior experience includes internships at OKRA Technologies, focusing on AI analytics for pharmaceuticals, and Cambridge Enterprise, where contributions were made to invest in academic-led startups. Additional internships at IQ Capital Partners LLP and Amadeus Capital Partners enhanced expertise in deep-tech VC and global technology investments, respectively. Education was completed at the University of Nottingham.
This person is not in any teams
This person is not in any offices
Nucleus Capital
Nucleus Capital is a new venture capital firm supporting purpose-driven founders. We profoundly believe that entrepreneurial innovation is necessary to tackle global threats to human and planetary health. We partner with entrepreneurs at the nucleus of their journey, investing at the Pre/Seed stage and are focussed on Synthetic &Computational Biology, Food- and Climate Technology.